Is vitamin K deficiency a risk factor for osteoporosis in Crohn's disease?

Lancet

Volumn 357, Issue 9273, 2001, Pages 1995-1996

  Szulc, Pawel ^a   Meunier, Pierre Jean ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DEOXYPYRIDINOLINE; FARNOQUINONE; GLUTAMIC ACID; LEUPRORELIN; MENATETRENONE; OSTEOCALCIN; PHYTOMENADIONE; PROSTAGLANDIN E2; PROSTAGLANDIN H; PROTEIN S; VITAMIN D; WARFARIN;

BONE ATROPHY; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CARBOXYLATION; CORTICAL BONE; CROHN DISEASE; DISEASE ACTIVITY; DISEASE DURATION; HIP FRACTURE; HUMAN; HYPOGONADISM; LIVER; MORPHOMETRICS; NOTE; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; RISK FACTOR; TRABECULAR BONE; VITAMIN DEFICIENCY; WEIGHT REDUCTION;

EID: 0035938975     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)05135-7     Document Type: Note

References (18)

1. 2 in human cortical and trabecular bone
2. Vitamin K
3. Comparison of biochemical indexes for assessing vitamin K nutritional status in a healthy adult population
4. 2 synthesis in vitro
5. Reduced bone density in patients with inflammatory bowel disease
6. Low serum and bone vitamin K status in patients with longstanding Crohn's disease: Another pathogenetic factor of osteoporosis in Crohn's disease
7. 2 decreased in elderly women with hip fracture
8. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women
9. Serum undercarboxylated osteocalcin is a markers of the risk of hip fracture in elderly women
10. 2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis
11. 1, rates of bone loss and risk of hip fracture in a prospective study of elderly women
12. Long-term use of oral anticoagulants and the risk of fracture
13. Similarities and differences between the effects of ipriflavone and vitamin K on bone resorption and formation in vitro
14. 2 (menatetrenone) on bone resorption may be related to its side chain
15. A four-year longitudinal study of bone loss in patients with inflammatory bowel disease
16. Bone loss in patients with inflammatory bowel disease: A prospective study
17. Genetic factors determine extent of bone loss in inflammatory bowel disease
18. Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease